Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy Q Cron

Showing results (31-40 of 189) with videos related to

Pageof 19
Sort By:
The Journal of Rheumatology|May 3, 2013
Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndromePhilip J Kahn, Randy Q Cron
The Journal of Rheumatology|March 27, 2020
The Rheumatologist's Role in COVID-19Randy Q Cron, W Winn Chatham
Rheumatic Diseases Clinics of North America|November 5, 2013
Treatment of juvenile idiopathic arthritis in the biologic ageMatthew L Stoll, Randy Q Cron
The Journal of Rheumatology|May 27, 2020
Drs. Cron and Chatham replyW Winn Chatham, Randy Q Cron
Genes and Immunity|April 16, 2020
The genetics of macrophage activation syndromeGrant S Schulert, Randy Q Cron
The Journal of Rheumatology|June 10, 2020
Drs. Cron and Chatham replyRandy Q Cron, W Winn Chatham
Arthritis Care & Research|August 5, 2022
To Wean or Not to Wean: That is the QuestionMelissa L Mannion, Randy Q Cron
ACR Open Rheumatology|August 25, 2021
Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID-19 and Multisystem Inflammatory Syndrome in ChildrenDaniel D Reiff, Randy Q Cron
Current Opinion in Pharmacology|April 23, 2022
Therapeutic strategies for treating juvenile idiopathic arthritisMelissa L Mannion, Randy Q Cron
The Journal of Rheumatology|April 4, 2006
Septic abscess in a child with juvenile idiopathic arthritis receiving anti-tumor necrosis factor-alphaPamela G Fitch, Randy Q Cron
Pageof 19

Showing results (31-40 of 189) with videos related to

Sort By:
Pageof 19
The Journal of Rheumatology|May 3, 2013
Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndromePhilip J Kahn, Randy Q Cron
The Journal of Rheumatology|March 27, 2020
The Rheumatologist's Role in COVID-19Randy Q Cron, W Winn Chatham
Rheumatic Diseases Clinics of North America|November 5, 2013
Treatment of juvenile idiopathic arthritis in the biologic ageMatthew L Stoll, Randy Q Cron
The Journal of Rheumatology|May 27, 2020
Drs. Cron and Chatham replyW Winn Chatham, Randy Q Cron
Genes and Immunity|April 16, 2020
The genetics of macrophage activation syndromeGrant S Schulert, Randy Q Cron
The Journal of Rheumatology|June 10, 2020
Drs. Cron and Chatham replyRandy Q Cron, W Winn Chatham
Arthritis Care & Research|August 5, 2022
To Wean or Not to Wean: That is the QuestionMelissa L Mannion, Randy Q Cron
ACR Open Rheumatology|August 25, 2021
Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID-19 and Multisystem Inflammatory Syndrome in ChildrenDaniel D Reiff, Randy Q Cron
Current Opinion in Pharmacology|April 23, 2022
Therapeutic strategies for treating juvenile idiopathic arthritisMelissa L Mannion, Randy Q Cron
The Journal of Rheumatology|April 4, 2006
Septic abscess in a child with juvenile idiopathic arthritis receiving anti-tumor necrosis factor-alphaPamela G Fitch, Randy Q Cron
Pageof 19